Home » BPC-157 (10mg Vial) Dosage Protocol

BPC-157 (10mg Vial) Dosage Protocol

Quickstart Highlights

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties^[1]^[2]. Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity^[3], though human clinical data remain limited to early-phase safety trials and small case reports^[4]^[5]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
Typical daily range: 200–600 mcg once daily (gradual titration).
Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL ≈ 50 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (2 mL = 5 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	200 mcg (0.2 mg)	4 units (0.06 mL)
Weeks 3–4	400 mcg (0.4 mg)	12 units (0.12 mL)
Weeks 5–8+	600 mcg (0.6 mg)	18 units (0.18 mL)

Frequency: Inject once daily subcutaneously. Dosing is extrapolated from preclinical models^[1]^[6]; human clinical validation remains limited.

Reconstitution Steps

Draw 2.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (BPC-157, 10 mg each):
- 8 weeks ≈ 3 vials (25.2 mg used)
- 12 weeks ≈ 5 vials (42 mg used)
- 16 weeks ≈ 6 vials (58.8 mg used)
Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~2.0 mL per vial for reconstitution.
- 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
- 12 weeks (5 vials): 15 mL → 1× 10 mL bottles
- 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support tissue-healing and recovery processes based on preclinical evidence^[1]^[3].
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range: 200–600 mcg daily with gradual titration.
Reconstitution: 2.0 mL per 10 mg vial (5 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

Start: 200 mcg daily; increase by ~200 mcg every 2 weeks as tolerated.
Target: 400–600 mcg daily by Weeks 5–8+.
Frequency: Once per day (subcutaneous).
Cycle Length: 8–12 weeks; optional extension to 16 weeks.
Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container^[7].
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation^[8].
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
BPC-157 human data are preliminary; clinical decisions should involve qualified healthcare providers.

How This Works

BPC-157 is a synthetic peptide corresponding to a partial sequence of human gastric juice protein^[2]. Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues^[1]^[3]. Animal models report accelerated healing of gut, tendon, ligament, and muscle injuries^[6]. A Phase I oral safety trial has been completed^[9], and a small human case series reported improvements following intra-articular administration^[5]; however, large-scale controlled human efficacy data are not yet available.

Potential Benefits & Side Effects

Observations from preclinical and early clinical literature.

Supports tissue repair in gut, tendon, muscle, and skin injury models (animal data)^[1]^[3].
Demonstrates anti-inflammatory and cytoprotective properties in preclinical settings^[6].
Phase I safety studies report good tolerability with no serious adverse events at tested doses^[9].
Occasional mild injection-site reactions (redness, itch) may occur with subcutaneous administration.
Long-term human safety and efficacy remain under investigation^[4].

Lifestyle Factors

Complementary strategies for best outcomes.

Support recovery with adequate protein intake and micronutrient-rich foods.
Balance activity and rest to allow tissue adaptation without overuse.
Prioritize sleep and stress management to enhance natural healing processes.
Consult qualified healthcare providers for injury-specific rehabilitation guidance.

Injection Technique

General subcutaneous guidance from clinical best-practice resources^[10]^[11].

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[10].
Do not aspirate for subcutaneous injections; inject slowly and steadily^[10].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy^[8].
Discard used syringes immediately in a sharps container per WHO guidelines^[7].

Recommended Source

We recommend Fit Aminos for high-purity BPC-157 (10 mg).

Why Pure Lab Peptides?

High-purity, third-party-tested lots with batch COAs.
Consistent, ISO-aligned handling and documentation.
Reliable fulfillment to maintain cold-chain integrity.

Shop at Fit Aminos

Important Note

This content is for educational purposes only and is not medical advice, diagnosis, or treatment. BPC-157 remains investigational with limited human clinical data. For research use only. Not for human consumption.

References

Journal of Pharmacological Sciences
— Klicek R et al. BPC-157 promotes colocutaneous fistula healing via NO-system modulation (rat model)